Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2023 03:00 ET | Source: Sitryx Therapeutics

Sitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases

Lilly exercises option to an exclusive worldwide license to develop and commercialize SIT-011, a Phase 1 ready immunometabolism-targeting therapy for chronic autoimmune and inflammatory...
April 15, 2021 02:00 ET | Source: Sitryx Therapeutics

Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer

Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer Oxford, UK – 15 April 2021 – Sitryx (“the Company”), a biopharmaceutical company...
March 24, 2021 03:00 ET | Source: Sitryx Therapeutics

Sitryx appoints Pierre Legault as Chairman of its Board of Directors

Sitryx appoints Pierre Legault as Chairman of its Board of Directors Oxford, UK – 24 March 2021 - Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop...